tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:6MK Stock Latest News

Merck enters R&D funding agreement with Blackstone Life Sciences
The FlyMerck enters R&D funding agreement with Blackstone Life Sciences
21h ago
MRK
Merck enters R&D funding agreement with Blackstone for sac-TMT
PremiumThe Fly
Merck enters R&D funding agreement with Blackstone for sac-TMT
21h ago
BX
MRK
Merck signs agreement with Dr. Falk Pharma GmbH regarding MK-8690
PremiumThe Fly
Merck signs agreement with Dr. Falk Pharma GmbH regarding MK-8690
21h ago
MRK
Merck price target raised to $100 from $98 at Morgan Stanley
PremiumThe Fly
Merck price target raised to $100 from $98 at Morgan Stanley
2d ago
MRK
Merck & Co. Earnings Call Highlights Strong Growth
PremiumCompany Announcements
Merck & Co. Earnings Call Highlights Strong Growth
4d ago
MRK
Merck & Co. Hold Rating: Navigating Stabilized Revenue and Keytruda’s Exclusivity Challenges
PremiumRatingsMerck & Co. Hold Rating: Navigating Stabilized Revenue and Keytruda’s Exclusivity Challenges
5d ago
MRK
Adagene says first patient dosed in Phase 2 study of muzastotug, KEYTRUDA
Premium
The Fly
Adagene says first patient dosed in Phase 2 study of muzastotug, KEYTRUDA
5d ago
MRK
ADAG
Merck & Company: Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
Premium
Ratings
Merck & Company: Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
5d ago
MRK
Merck Reports Strong Q3 2025 Financial Performance
PremiumCompany Announcements
Merck Reports Strong Q3 2025 Financial Performance
5d ago
MRK
Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
PremiumThe Fly
Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
6d ago
BA
CI
Morning Movers: Alphabet, Eli Lilly rise following quarterly results
PremiumThe Fly
Morning Movers: Alphabet, Eli Lilly rise following quarterly results
6d ago
CI
MA
Merck reports Q3 adjusted EPS $2.58, consensus $2.35
PremiumThe Fly
Merck reports Q3 adjusted EPS $2.58, consensus $2.35
6d ago
MRK
Merck raises FY25 adjusted EPS view to $8.93-$8.98 from $8.87-$8.97
PremiumThe FlyMerck raises FY25 adjusted EPS view to $8.93-$8.98 from $8.87-$8.97
6d ago
MRK
FDA moves to accelerate biosimilar development, lower drug costs
Premium
The Fly
FDA moves to accelerate biosimilar development, lower drug costs
6d ago
AZN
BMY
Notable companies reporting before tomorrow’s open
Premium
The Fly
Notable companies reporting before tomorrow’s open
7d ago
K
CI
Merck, Eisai provide update on LEAP-012 trial
PremiumThe Fly
Merck, Eisai provide update on LEAP-012 trial
7d ago
MRK
Merck: EC approves Keytruda for treatment of LA-HNSCC
PremiumThe Fly
Merck: EC approves Keytruda for treatment of LA-HNSCC
7d ago
MRK
Merck reports ‘positive’ results from Phase 3 LITESPARK-022 trial
PremiumThe Fly
Merck reports ‘positive’ results from Phase 3 LITESPARK-022 trial
8d ago
MRK
Merck, Eisai: Phase 3 LITESPARK-011 trial met primary endpoints
PremiumThe Fly
Merck, Eisai: Phase 3 LITESPARK-011 trial met primary endpoints
8d ago
MRK
Merck & Company (MRK) Q3 Earnings Cheat Sheet
PremiumPre-EarningsMerck & Company (MRK) Q3 Earnings Cheat Sheet
8d ago
MRK
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
Premium
The Fly
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
9d ago
LLY
MRK
Merck says FDA approves updated indication for WINREVAIR
Premium
The Fly
Merck says FDA approves updated indication for WINREVAIR
9d ago
MRK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >